Clinical trials for Heart-lung transplant

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Heart-lung transplant. For all clinical trials, go to clinical trials search

This list shows clinical trials for Heart-lung transplant

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Heart-lung transplant
Title Recruitment status Location
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation Recruiting United Kingdom
An assessment of patient outcomes following a rehabilitation programme for patients who have received heart/lung or lung transplant - a randomised controlled pilot trial Not Recruiting United Kingdom
A 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing de Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (using C2 monitoring) and Corticosteroids for the Prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant Recipients. (CERL080A2415) Not Recruiting United Kingdom
An observational study of i)mini-area-under-the-curve (mini-AUC) estimation of exposure to mycophenolic acid (MPA) in heart transplant and lung transplant recipients on mycophenolate mofetil (MMF)or Mycophenolate Sodium (Myfortic) ii) utility of salivary measurements of MPA levels in heart & lung transplant recipients. - Simultaneous estimation of Myclophenolic Acid in saliva and blood in heart and lung transplant patie Authorised United Kingdom
AZITHROMYCIN IN BRONCHIOLITIS OBLITERANS SYNDROME - AZI001 Not Recruiting Belgium
Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event Reduction Not recruiting France
Empowerment of Lung and Heart-lung Transplant Patients Not recruiting Germany
A prospective, open-label, pilot-study of azithromycin for lymphocytic bronchi(oli)tis after lung transplantation - Azithromycin in lymphocytic bronchi(oli)tis Not Recruiting Belgium
A 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing de Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (using C2 monitoring) and Corticosteroids for the Prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant Recipients. (CERL080A2415) Not Recruiting Austria
A 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing de Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (using C2 monitoring) and Corticosteroids for the Prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant Recipients. (CERL080A2415) Not Recruiting Germany

Page last reviewed:

Next review due: